Abstract

Surfactants are widely used for enhanced oil recovery (EOR) purposes by reducing interfacial tension (IFT) of oil–water phases and wettability alteration. Some surfactants with viscoelastic properties can be used as mobility control agents due to enhanced viscosity resulting from the spherical-to-cylindrical shape transition of micelles. Dodecyltrimethylammonium chloride (DAC) shows viscoelastic behavior coupled with dominantly cylindrical shape of the micelle in ambient conditions. Nevertheless, using DAC as an IFT reduction and mobility control agent needs to be industrialized for actual operating conditions. In this study, DAC, as a cationic surfactant, was experimentally studied in reservoir conditions considering dominantly cylindrical micelles for the first time. Results showed that the viscosity of DAC solution is a strong function of DAC concentration, especially at high temperature and high salinity conditions, while it does not depend on pressure significantly. Transmission electron microscope (TEM) images were taken for a better understanding of DAC micellar structures. Analysis of the TEM results indicated the shape transition of the micelles from small spherical to large cylindrical at higher concentrations of DAC. IFT of DAC microemulsion was studied for wide ranges of temperature and DAC concentration, ruling out any significant effect of the temperature on the IFT trend line. A general mathematical model for predicting the viscosity of surfactant solution was developed and evaluated for real reservoir conditions by including all effective terms. Results showed a very good agreement with experimental data of DAC and Cetyltrimethyl ammonium bromide (CTAB, as per previous studies), justifying the applicability of the developed model for predicting the viscosity wherever experimental data is unavailable. Core flood tests were performed with saltwater (SW) and DAC solutions with spherical (SS) and cylindrical (SC) micelles as injecting phases for evaluation of IFT reduction and mobility control effects. Results showed an additional recovery factor of 13 % for SS and 23 % for SC in comparison with SW injection.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call